To include your compound in the COVID-19 Resource Center, submit it here.

Millennium, Abbott deal

The companies will develop therapeutics and diagnostics for obesity and diabetes, and share certain discovery technologies. Under the five-year deal,

Read the full 200 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE